Dexcom (DXCM) Enterprise Value (2010 - 2026)

Dexcom (DXCM) has 17 years of Enterprise Value data on file, last reported at -$1.1 billion in Q1 2026.

• On a quarterly basis, Enterprise Value rose 58.61% year-over-year to -$1.1 billion in Q1 2026; TTM through Mar 2026 was -$1.1 billion, a 58.61% increase from a year earlier, with the FY2025 full-year figure at -$917.7 million, up 56.46% from the prior year.
• Enterprise Value for Q1 2026 stood at -$1.1 billion, down from -$917.7 million in the prior quarter.
• Over the last five years, Enterprise Value for DXCM reached as high as -$917.7 million in Q4 2025 and fell as low as -$3.6 billion in Q2 2023.
• Historically, Enterprise Value has averaged -$2.4 billion across 5 years, with a median of -$2.6 billion in 2023.
• Across the five-year window, Enterprise Value plunged 36.61% in 2023 and jumped 62.86% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$2.5 billion in 2022, then dropped by 10.91% to -$2.7 billion in 2023, then advanced by 22.63% to -$2.1 billion in 2024, then soared by 56.46% to -$917.7 million in 2025, then fell by 21.85% to -$1.1 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$1.1 billion in Q1 2026, -$917.7 million in Q4 2025, and -$1.4 billion in Q3 2025.